If you pick up a recent copy of Los Angeles Business Journal, you'll see some familiar names and faces.
Drs. Ruey-Kang Chang, Paul Lee, and Laszlo Boros are each featured prominently in the November 4-10 print issue of LA Business Journal. The article highlights the business acumen of these Harbor-UCLA pediatricians who each have turned their inventions and discoveries into profit in the private sector.
Dr. Ruey-Kan Chang is the chief executive officer of QT Medical, a company he founded that will commercialize Dr. Chang's inventions; among them is a baby monitor that prevents Sudden Infant Death Syndrom (SIDS).
He said working at LA BioMed has provided him with the time and resources to work on these projects in between his work [teaching] residents at Harbor-UCLA Medical Center on the same campus. The institute provided expertise in getting grants and collegial support. "They give me so much flexibility and support in being inventive in my research," he said. "It’s the reason I’m still working here."
Dr. Chang is a pediatric cardiologist focused on public health issues related to infants and children with heart disease. His research has centered on the prevention of sudden death from silent or undiagnosed heart conditions and he has authored numerous publications on the subject.
The article includes Drs. Paul Lee and Laszlo Boros and their equally exciting joint venture Sidmap. Sidmap works to expedite the process of drug testing by allowing pharmaceutical companies and small labs to send samples to them for testing results and analysis. Using their methods of Drs. Lee and Boros, what normally takes years is delivered to clients in up to six weeks.
Researchers at drug companies, independent labs and universities send samples and test results to Sidmap for analysis. Clients can use the results to verify their success or to invalidate faulty research and stop it earlier
Read the rest of the story of the doctors and their fascinating partner Agi Hirshberg.